Awakn Life Sciences (TSE:AWKN) has released an update.
Awakn Life Sciences Corp., a biotech firm focusing on treatments for substance use and mental health disorders, has completed another tranche of its private placement, raising an additional $197,143 through unit issuance. The company also extended the expiry of certain warrants, which is deemed a related party transaction, yet falls under exemption guidelines due to its market cap proportion.
For further insights into TSE:AWKN stock, check out TipRanks’ Stock Analysis page.
